Among PKC isoforms, PKCα may play a major role because specifically targeting this PKC isoform through chemical inhibition or transcriptional suppression permits attenuation or reversal of drug resistance of human cancer cell lines [86,87,88,89], whereas its overexpression enhances P-gp phosphorylation and multidrug resistance [90,91]. Here, PRRT2 is linked to cancer.